Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 1;72(4):929–944. doi: 10.1007/s00262-022-03301-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 4 — Analysis of the T cell receptor V beta gene repertoire. a Effector CTLs in indolent-type ATLL patients. The upper, middle, and lower panels indicate data of Indolent-1, Indolent-2, and Indolent-3, respectively. b Memory CTLs in indolent-type ATLL patients. The upper, middle, and lower panels indicate data of Indolent-1, Indolent-2, and Indolent-3, respectively. c Effector CTLs in aggressive-type ATLL patients. The upper, middle, and lower panels indicate data of Aggressive-1, Aggressive-2, and Aggressive-3, respectively. d Memory CTLs in aggressive-type ATLL patients. The upper, middle, and lower panels indicate data of Aggressive-1, Aggressive-2, and Aggressive-3, respectively. Vb, V beta gene; Pre, Pre-VZV vaccination; 1st Vac., First VZV vaccination; 2nd Vac., Second VZV vaccination; M, Month(s) after VZV vaccination; 2 W, 2 weeks after VZV vaccination

Fig. 4 — Analysis of the T cell receptor V beta gene repertoire. a Effector CTLs in indolent-type ATLL patients. The upper, middle, and lower panels indicate data of Indolent-1, Indolent-2, and Indolent-3, respectively. b Memory CTLs in indolent-type ATLL patients. The upper, middle, and lower panels indicate data of Indolent-1, Indolent-2, and Indolent-3, respectively. c Effector CTLs in aggressive-type ATLL patients. The upper, middle, and lower panels indicate data of Aggressive-1, Aggressive-2, and Aggressive-3, respectively. d Memory CTLs in aggressive-type ATLL patients. The upper, middle, and lower panels indicate data of Aggressive-1, Aggressive-2, and Aggressive-3, respectively. Vb, V beta gene; Pre, Pre-VZV vaccination; 1st Vac., First VZV vaccination; 2nd Vac., Second VZV vaccination; M, Month(s) after VZV vaccination; 2 W, 2 weeks after VZV vaccination